Organizational and Personnel Changes

TOKYO, January 30, 2025 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced the following organizational and personnel changes, effective March 27 and April 1, 2025, respectively.

[Details of Organizational Changes]

Integration of Business Transformation Dept. into ASPIRE Transformation Dept.

Chugai established ASPIRE^* Transformation (AX) Dept. on January 1, 2023, aiming to promote business process reform through the implementation of a next-generation core business infrastructure (ERP: enterprise resource planning system). Furthermore, on July 1, 2023, Chugai established Business Transformation (BX) Dept. as an organization responsible for company-wide business process reform and the establishment of a Business Process Management (BPM) framework. Chugai has been advancing company-wide reforms under the two frameworks, AX and BX.
As Chugai enters a phase to address BPM challenges associated with the ASPIRE implementation from 2025, the functions of BX Dept. will be integrated into AX Dept. to promote those initiatives more smoothly. AX Dept. will tackle BPM challenges related to the implementation of ASPIRE and associated programs. Furthermore, the company-wide BPM framework will be maintained, and efforts to address BPM challenges outside of ASPIRE will continue.

• Dissolution of BX Dept.
• Transfer of BPM promotion functions and other responsibilities previously handled by BX Dept. to AX Dept.

*ASPIRE: The name of a business and digital transformation program that will deliver cutting-edge global standard processes and the next-generation ERP platforms across Chugai Group

[Details of Personnel Changes]
Effective March 27, 2025

Directors

• The appointment of Thomas Schinecker and Boris L. Zaïtra as Directors is subject to approval at the 114th Annual General Meeting of Shareholders, which is scheduled to be convened on March 27, 2025.
• Christoph Franz is scheduled to retire from Director as of March 27, 2025.

Audit & Supervisory Board Members

• The appointment of Masayoshi Higuchi as Audit & Supervisory Board Members is subject to approval at the 114th Annual General Meeting of Shareholders, which is scheduled to be convened on March 27, 2025.
• Yoshiaki Ohashi is scheduled to retire from Audit & Supervisory Board Member as of March 27, 2025.

Effective April 1, 2025

Executive Officers

• Tetsuya Yamaguchi and Junichi Ebihara are scheduled to retire from Executive Vice Presidents as of March 31, 2025.

Associate Vice Presidents